Can naproxen and Coveram (perindopril/amlodipine) 5mg/5mg be taken together?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Naproxen and Coveram 5mg/5mg (Perindopril/Amlodipine) Interaction

Naproxen and Coveram 5mg/5mg (perindopril/amlodipine) can be taken together, but caution is advised as NSAIDs like naproxen may reduce the antihypertensive effectiveness of ACE inhibitors like perindopril and potentially increase risk of renal impairment. 1

Mechanism of Interaction

  • NSAIDs like naproxen can attenuate the blood pressure-lowering effects of several antihypertensive medications, including ACE inhibitors like perindopril 1
  • NSAIDs inhibit prostaglandin synthesis, which can interfere with the vasodilatory and natriuretic effects of ACE inhibitors 1
  • This interaction may result in reduced effectiveness of the antihypertensive therapy and potentially elevated blood pressure 1

Risk Assessment

  • The combination presents several potential concerns:
    • Reduced antihypertensive efficacy: NSAIDs may diminish the blood pressure-lowering effect of Coveram 1
    • Renal function: Both ACE inhibitors and NSAIDs can affect kidney function, and their combination may increase the risk of acute renal impairment, particularly in patients with pre-existing renal dysfunction 1
    • Electrolyte disturbances: The combination may increase the risk of hyperkalemia in susceptible patients 1

Recommendations for Clinical Management

Monitoring Requirements

  • Blood pressure should be closely monitored when initiating naproxen in patients on Coveram to ensure adequate blood pressure control is maintained 1
  • Renal function and electrolytes should be checked:
    • Before starting the combination
    • Within 1-2 weeks after initiation
    • After any dose adjustments 1

Patient Selection

  • Use extra caution in patients with:
    • Pre-existing renal impairment (creatinine >221 μmol/L or eGFR <30 mL/min/1.73 m²) 1
    • Elderly patients (>65 years) 1
    • Patients with heart failure 1
    • Patients with volume depletion 1

Dosing Considerations

  • Use the lowest effective dose of naproxen for the shortest duration possible 1
  • Consider temporary adjustment of Coveram dosage if blood pressure control deteriorates after adding naproxen 1
  • If long-term NSAID therapy is required, consider alternative antihypertensive strategies that may be less affected by NSAIDs 1

Alternative Approaches

  • For pain management, consider non-NSAID analgesics (e.g., acetaminophen) when appropriate, which have minimal impact on blood pressure control 1
  • If an NSAID is necessary, consider using it intermittently rather than continuously to minimize impact on blood pressure control 1
  • For patients requiring triple antihypertensive therapy, perindopril/indapamide/amlodipine combinations have shown good efficacy and tolerability 2, 3

Common Pitfalls to Avoid

  • Failing to monitor blood pressure after initiating naproxen therapy in patients on Coveram 1
  • Overlooking signs of deteriorating renal function, which may occur rapidly in susceptible patients 1
  • Not educating patients about potential symptoms of adverse reactions that should prompt medical attention (e.g., edema, significant weight gain, decreased urine output) 1
  • Ignoring the potential for drug interactions with other medications the patient may be taking 1

In conclusion, while naproxen and Coveram can be used together, this combination requires careful monitoring of blood pressure and renal function, with appropriate dose adjustments as needed to maintain efficacy and minimize adverse effects.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Perindopril/Indapamide/Amlodipine in Hypertension: A Profile of Its Use.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.